SCHEMBL17828992

SCHEMBL17828992

c1ccc(-c2nc(-c3ccc(-n4c5ccccc5c5ccc(-n6c7ccccc7c7ccccc76)cc54)cc3)nc3ccc4ccccc4c23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPT P10636 4/20 0.39
NPC1 O15118 3/20 0.39
LMNA P02545 3/20 0.39
RAB9A P51151 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
RECQL P46063 1/20 0.39
KDM4E B2RXH2 3/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PTGES O14684 2/20 0.36
HPGD P15428 3/20 0.36
ALDH1A1 P00352 2/20 0.36
WHR1 P49842 1/20 0.35
F2 P00734 1/20 0.34
F10 P00742 1/20 0.34
PRSS1 P07477 1/20 0.34
HTT P42858 3/20 0.33
ABCG2 Q9UNQ0 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17828977 0.99 ATM (0.39) ATMMEN1KMT2AMAPTNPC1
SCHEMBL17828952 0.92 F2 (0.37) ATMMEN1KMT2AMAPTNPC1
SCHEMBL17828978 0.92 PTGES (0.40) ATMMEN1KMT2AMAPTNPC1
SCHEMBL17828969 0.91 PTGES (0.39) ATMMEN1KMT2AMAPTNPC1
SCHEMBL17828910 0.90 KDM4E (0.38) ATMMEN1KMT2AMAPTNPC1
SCHEMBL17828970 0.90 PTGES (0.42) ATMMEN1KMT2AMAPTNPC1
SCHEMBL17828987 0.89 PTGES (0.41) ATMMEN1KMT2AMAPTNPC1
SCHEMBL17828963 0.89 MAPT (0.34) ATMMEN1KMT2AMAPTNPC1
SCHEMBL17878992 0.89 PTGES (0.42) ATMMEN1KMT2AMAPTNPC1
SCHEMBL17879001 0.89 PTGES (0.42) ATMMEN1KMT2AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9508939-B2 Compound and organic electroluminescent element produced using same IDEMITSU KOSAN CO., LTD. (JP) 2016-11-29 US disclosed
US-9508939-B2 Compound and organic electroluminescent element produced using same IDEMITSU KOSAN CO., LTD. (JP) 2016-11-29 US disclosed
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-16 US disclosed
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME L1CAM, LEF1, EML4 ATM 2921/4885MEN1 94/4885KMT2A 1859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.